| Primary |
| Chronic Obstructive Pulmonary Disease |
35.7% |
| Emphysema |
15.1% |
| Hypertension |
12.0% |
| Asthma |
5.3% |
| Diabetes Mellitus |
4.8% |
| Dyspnoea |
3.8% |
| Osteoporosis |
3.4% |
| Lung Disorder |
3.1% |
| Depression |
2.6% |
| Fatigue |
2.2% |
| Bronchitis |
1.7% |
| Blood Cholesterol |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Cardiac Disorder |
1.4% |
| Arrhythmia |
1.2% |
| Cough |
1.2% |
| Diuretic Therapy |
1.0% |
| Dyspepsia |
1.0% |
| Respiratory Disorder |
1.0% |
| Abdominal Discomfort |
0.7% |
|
| Death |
13.8% |
| Pneumonia |
12.8% |
| Dyspnoea |
7.4% |
| Respiratory Failure |
7.4% |
| Lung Disorder |
6.4% |
| Chronic Obstructive Pulmonary Disease |
5.3% |
| Emphysema |
5.3% |
| Cardiac Arrest |
4.3% |
| Lower Respiratory Tract Infection |
4.3% |
| Respiratory Tract Infection |
4.3% |
| Sepsis |
4.3% |
| Cardiac Failure |
3.2% |
| Respiratory Arrest |
3.2% |
| Tachycardia |
3.2% |
| Urinary Tract Infection |
3.2% |
| Viral Diarrhoea |
3.2% |
| Bronchopneumonia |
2.1% |
| Cardio-respiratory Arrest |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Chest Discomfort |
2.1% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
25.0% |
| Emphysema |
23.9% |
| Asthma |
12.0% |
| Dyspnoea |
12.0% |
| Cough |
5.4% |
| Hypertension |
4.3% |
| Bronchitis |
3.3% |
| Diabetes Mellitus |
2.2% |
| Lung Neoplasm Malignant |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Abdominal Discomfort |
1.1% |
| Cardiac Disorder |
1.1% |
| Cerebrovascular Accident Prophylaxis |
1.1% |
| Epilepsy |
1.1% |
| Gastritis |
1.1% |
| Pulmonary Oedema |
1.1% |
| Renal Disorder |
1.1% |
|
| Pneumonia |
15.8% |
| Urinary Tract Infection |
15.8% |
| Lung Neoplasm Malignant |
10.5% |
| Malaise |
10.5% |
| Cardiac Arrest |
5.3% |
| Chronic Obstructive Pulmonary Disease |
5.3% |
| Cough |
5.3% |
| Dyspnoea |
5.3% |
| Emphysema |
5.3% |
| Hypersensitivity |
5.3% |
| Hypertension |
5.3% |
| Influenza |
5.3% |
| Nausea |
5.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
45.9% |
| Chronic Obstructive Pulmonary Disease |
8.2% |
| Cough |
4.6% |
| Non-small Cell Lung Cancer |
4.6% |
| Pain |
4.6% |
| Bronchitis |
3.6% |
| Sleep Disorder |
3.6% |
| Emphysema |
3.1% |
| Hypertension |
3.1% |
| Prophylaxis |
3.1% |
| Sputum Discoloured |
3.1% |
| Connective Tissue Disorder |
2.1% |
| Hyperparathyroidism Secondary |
2.1% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Infection |
1.5% |
| Age-related Macular Degeneration |
1.0% |
| Analgesic Therapy |
1.0% |
| Cardiovascular Event Prophylaxis |
1.0% |
| Diagnostic Procedure |
1.0% |
| Dyspnoea |
1.0% |
|
| Blood Sodium Decreased |
7.7% |
| Chronic Obstructive Pulmonary Disease |
7.7% |
| Endophthalmitis |
7.7% |
| Hypotension |
7.7% |
| Myocardial Infarction |
7.7% |
| Nausea |
7.7% |
| Blood Pressure Increased |
3.8% |
| Condition Aggravated |
3.8% |
| Death |
3.8% |
| Dysphonia |
3.8% |
| Dyspnoea |
3.8% |
| Haematochezia |
3.8% |
| Haemoglobin Decreased |
3.8% |
| Haemorrhagic Diathesis |
3.8% |
| Hepatitis Cholestatic |
3.8% |
| Hypomagnesaemia |
3.8% |
| Hyponatraemia |
3.8% |
| Inappropriate Antidiuretic Hormone Secretion |
3.8% |
| Malaise |
3.8% |
| Mental Disorder |
3.8% |
|
